期刊文献+

核黄素联合紫外线A照射对血浆中伪狂犬病毒的灭活效果 被引量:5

Inactivation of pseudorabies virus in plasma using riboflavin and ultraviolet light
下载PDF
导出
摘要 目的考察核黄素联合紫外线A对血浆中伪狂犬病毒的灭活效果。方法以伪狂犬病毒为模拟病毒,以Vero细胞为培养细胞,用病毒感染细胞,制备病毒增殖液;分别采用5、10、15及20J/cm2联合核黄素处理血浆,观察处理前后血浆病毒灭活的效果,筛选灭活病毒合适的紫外线剂量;将含有伪狂犬病毒血浆的样本分为实验组:采用上述筛选的紫外线强度照射联合核黄素处理;对照组1:单独采用紫外线A照射;对照组2:单独采用核黄素处理;阴性对照组:未采用紫外线照射和核黄素处理;分别在实验前后采用96孔细胞病变法,对照细胞病变效应,根据Reed-Muench公式计算病毒滴度。结果采用不同强度的紫外线联合核黄素处理血浆,紫外线强度为15及20J/cm2的灭活血浆病毒的效果明显,处理后病毒滴度分别下降4.55和4.39logs;实验组和对照组1病毒滴度分别下降4.55和4.28logs,有统计学意义(P<0.05);对照组2病毒滴度降低1.93logs,没有病毒灭活效果。结论核黄素联合紫外线可灭活血浆中伪狂犬病毒,单独紫外线照射也具有灭活血浆伪狂犬病毒的效果;而仅单独采用核黄素处理而未联合紫外线照射,对血浆中伪狂犬病毒灭活效果不明显。 Objective To study the inactivation efficiency of riboflavin and ultraviolet A light (UV-A, 320-400nm) on pseudorabies virus in plasma. Methods Pseudorabies virus were cultured with Veto cells, and Riboflavin was added into plasma With a final concentration of 50μmol/L, and then exposed to ultraviolet A at 5,10,15 and 20J/ cm^2 UV-A for 30 minutes, respectively, to chose the optimal dose of UV-A exposure. Then 4 groups, each group with 5ml plasma mixed with 10μl virus-infected Veto cells, were assigned as follows: experimental group., underwent UV-A exposure at 15J/cm^2 for 30 minutes with Riboflavin at a concentration of 50μmol/L; control group 1 : 15J/cm^2 UV-A exposure for 30 minutes without riboflavin; control group 2 : use riboflavin of 50μmol/L only without UV-A exposure; negative control group., neither UV-A exposure nor riboflavin treatment was used. Virus titer was measured by TCID50, and the changes of the titer throughout the inactivation were analyzed statistically. Results UV-A exposure at 15 and 20J/cm^2 for 30 minutes with riboflavin of 50μmol/L were effective in inactivation, and the virulence of pseudorabies virus drop 4.55 and 4.39 logs, respectively. The viral virulence of experimental group was reduced by 4. 55 logs, and control group 1 by 4. 28 logs, while control group 2 didn't achieve the inactivation efficacy expected. Conclusion Both the combination of riboflavin and UV-A light, and UV-A treatment only could effectively inactivate pseudorabies virus in plasma. But the use of riboflavin only couldn't achieve effective inactivation.
出处 《中国输血杂志》 CAS CSCD 2007年第5期361-364,共4页 Chinese Journal of Blood Transfusion
基金 广东省医学科研基金(NO.B2003134) 广州市医药卫生科研项目(NO.2004YB117)联合资助课题
关键词 病毒灭活 血浆 核黄素 紫外线A 模拟病毒 伪狂犬病毒 VERO细胞 Riboflavin Ultraviolet A Plasmas Pseudorabies virus
  • 相关文献

参考文献13

  • 1Cummings PD, Wallace EL, Schorr JB, et al. Exposure of patients to human immunodeficiency virus through the transfusion of blood components that test antibody negative[J]. N Engl J Med. 1998, 321:942--946
  • 2Kumar V, Loekerbie O, Keil SD, et al, Riboflavin and UV- light based pathogen reduction: extent and consequence of DNAdamage at the molecular level[J]. Photochem Photeblol, 2004,80(1):15--21.
  • 3Goodrich L, Ghielli M, Hansen E, et al. Riboflavin and UV light inactivate enveloped and non-envelop viruses in platelet concentrates under conditions which maintain cell quallty[J].Vox Sang, 2002,83(2):111
  • 4黄桢祥.医学病毒学基础与实验技术[M].北京:科学技术出版社,1990:130-138
  • 5周铁群,邱平,王剑锋,李长贵.几种血液制品病毒灭活工艺的验证和评价[J].中国输血杂志,2001,14(4):219-221. 被引量:24
  • 6Ruane PH, Edrich R, Gampp D, et al. Photochemical inactivation of selected viruses and bacteria in platelet concentrates using riboflavin and light[J]. Transfusion, 2004,44:877--885
  • 7Li J, de Korte D, Woolum MD, et al. Pathogen reduction of bully coat platelet concentrates using riboflavin and lifht: comparisons with pathogen-reduction technology-treated apheresis platelet products[J]. Vox Sang, 2004,87(1) :82--90.
  • 8Aubuchon JP, Herschel L, Roger J, et al. Efficacy of apheresis platelets treated with riboflavin and ultraviolet light for pathogen reduction[J]. Transfusion, 2005,45(8) :1335-- 1341
  • 9Roback JD, Conlan M, Drew WJ, et al. Then role of photochemical treatment with Amotosalen and UV-A light in the prevention of transfusion-transmitted cytomegalovirus infections. Transfusion Med Rev, 2006, 20(1): 45--56
  • 10Busch MP, Kleinman SH, Nemo GJ, Current and emerging infectious risks of blood transfusions[J]. J Am Med Assoc, 2003,289(8):959--962

二级参考文献4

共引文献23

同被引文献54

引证文献5

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部